Chemical Structure : Tislelizumab
CAS No.: 1858168-59-8
货号: PC-Ab1067Not For Human Use, Lab Use Only.
Tislelizumab (BGB-A317) is a humanized IgG4 anti-PD-1 monoclonal antibody specifically designed to minimize binding to FcγR on macrophages. Tislelizumab (BGB-A317) binds to and blocks human PD-1 with high affinity and specificity, shows anti-tumor activity through activation of antibody-dependent macrophage-mediated killing of T effector cells..
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥3580 | In stock | |
5 mg | ¥7580 | In stock | |
10 mg | ¥12800 | In stock | |
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Tislelizumab (BGB-A317) is a humanized IgG4 anti-PD-1 monoclonal antibody specifically designed to minimize binding to FcγR on macrophages. Tislelizumab (BGB-A317) binds to and blocks human PD-1 with high affinity and specificity, shows anti-tumor activity through activation of antibody-dependent macrophage-mediated killing of T effector cells.
分子量 | ||
分子式 | Human IgG4P-Kappa | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
PBS, pH 7.0 Contains no stabilizers or preservatives |
|
Chemical Name/SMILES |
Tislelizumab; Tilelizumab; Tirelizumab; BGB-A317; CD279; programmed death-1; programmed death 1 ; anti-PD1; PD 1; Programmed cell death protein 1; hPD-1; hPD1; hPD 1 |
1. 1, Liu SY, et al. Expert Opin Investig Drugs. 2020 Dec;29(12):1355-1364. 2, Xu J, et al. Clin Cancer Res. 2020 Sep 1;26(17):4542-4550. 3, Shen L, et al. J Immunother Cancer. 2020 Jun;8(1):e000437. 4, Friedlander M, et al. Lancet Oncol. 2019 Sep;20(9):1306-1315. 5, Song Y, et al. Leukemia. 2020 Feb;34(2):533-542.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright